Stay updated on Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The revision label at the bottom of the page updated from v3.3.1 to v3.3.2, which is a UI/version detail and does not affect study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:09:44.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The record history now includes Revision: v3.3.1 and removes Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:59:17.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A government funding/status notice that previously appeared on the page has been removed; the overall history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-17T06:26:10.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    New screenshot shows the same version history entries with only minor visual adjustments to headers and spacing; no core data or version entries were added or removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:08:01.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Major update: new operating-status notice and a v3.2.0 version release, replacing the prior v3.1.0.
    Difference
    10%
    Check dated 2025-10-05T09:35:08.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T03:08:58.000Z thumbnail image

Stay in the know with updates to Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.